Seelos

Seelos Therapeutics, Inc. (NASDAQ:SEEL), a biopharmaceutical company developing treatments for central nervous system disorders and rare diseases, announced that it received a notice on October 14, 2024, from the Nasdaq Hearings Panel to delist its common stock. This decision follows Seelos...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. While not on most people’s sexiest shroom stock list, Seelos Therapeutics has been a solid presence in the space for some time. For those who might not know, Seelos is a...

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first exchange traded fund providing exposure to the burgeoning industry of medicinal psychedelics. The ETF is managed by Horizons ETFs...